Published in Br J Ophthalmol on July 01, 2005
An update on the genetics of age-related macular degeneration. Mol Vis (2007) 1.95
Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina. Invest Ophthalmol Vis Sci (2010) 1.75
Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.70
Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology (2013) 1.43
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One (2009) 1.34
Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol (2009) 1.13
Quantitative fundus autofluorescence in healthy eyes. Invest Ophthalmol Vis Sci (2013) 1.11
Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area. Retina (2012) 1.07
Development of atrophy of the retinal pigment epithelium around disciform scars. Br J Ophthalmol (2006) 1.01
Use of fundus autofluorescence images to predict geographic atrophy progression. Retina (2011) 0.99
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest Ophthalmol Vis Sci (2013) 0.94
Fundus Autofluorescence and RPE Lipofuscin in Age-Related Macular Degeneration. J Clin Med (2014) 0.85
Fundus autofluorescence imaging: Fundamentals and clinical relevance. Saudi J Ophthalmol (2014) 0.85
Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera. Eye (Lond) (2014) 0.85
Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.84
Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMD. Graefes Arch Clin Exp Ophthalmol (2008) 0.83
Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2011) 0.83
Quantification of retinal pigment epithelial phenotypic variation using laser scanning cytometry. Mol Vis (2010) 0.81
Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells. Mol Vis (2014) 0.80
VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION. Retina (2016) 0.80
Clinical applications of age-related macular degeneration genetics. Cold Spring Harb Perspect Med (2014) 0.78
Semiautomatic Segmentation of Rim Area Focal Hyperautofluorescence Predicts Progression of Geographic Atrophy Due to Dry Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2016) 0.75
Fundus Autofluorescence in Age-related Macular Degeneration. Optom Vis Sci (2016) 0.75
Fundus autofluorescence applications in retinal imaging. Indian J Ophthalmol (2015) 0.75
Fundus autofluorescence and fate of glycoxidized particles injected into subretinal space in rabbit age-related macular degeneration model. Graefes Arch Clin Exp Ophthalmol (2009) 0.75
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci (1995) 5.29
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature (1993) 3.58
Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci (2001) 3.28
Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2001) 3.19
Senile macular degeneration: a case-control study. Am J Epidemiol (1983) 3.04
The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci (2000) 2.92
Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci (1984) 2.65
Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci (1986) 2.59
Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci (1989) 2.44
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31
The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1978) 2.30
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology (1999) 2.26
Fundus autofluorescence and age-related macular degeneration. Ophthalmology (2003) 2.13
Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (1999) 2.12
Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci (2001) 2.05
Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.93
Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (1999) 1.73
The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis (1999) 1.65
Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (2000) 1.64
Phenomics: fiction or the future? Trends Neurosci (2002) 1.63
Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Ophthalmology (1989) 1.53
Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J (2004) 1.48
Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci (2004) 1.45
Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol (1986) 1.34
Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34
Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.31
Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 1.09
Visualization of retinal pigment epithelial cells in vivo using digital high-resolution confocal scanning laser ophthalmoscopy. Am J Ophthalmol (2004) 1.02
[Topography of fundus autofluorescence with a new confocal scanning laser ophthalmoscope]. Ophthalmologe (1997) 1.01
Proteome analysis of lipofuscin in human retinal pigment epithelial cells. FEBS Lett (2002) 0.98
Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration. Arch Ophthalmol (2002) 0.95
Primer on medical genomics part V: bioinformatics. Mayo Clin Proc (2003) 0.93
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A (1993) 6.87
THE MEASUREMENT AND RECORDING OF GASTRODUODENAL BLOOD FLOW IN MAN BY MEANS OF A THERMAL GRADIENTOMETER. J Clin Invest (1942) 5.96
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev (2001) 5.79
Mortality among workers at Oak Ridge National Laboratory. Evidence of radiation effects in follow-up through 1984. JAMA (1991) 3.80
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Stroke in users of low-dose oral contraceptives. N Engl J Med (1996) 2.98
Secondary plasmodesmata are specific sites of localization of the tobacco mosaic virus movement protein in transgenic tobacco plants. Plant Cell (1992) 2.91
The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis (2001) 2.71
Stability increase of the lumbar spine with different muscle groups. A biomechanical in vitro study. Spine (Phila Pa 1976) (1995) 2.62
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol (2009) 2.60
Intensive livestock operations, health, and quality of life among eastern North Carolina residents. Environ Health Perspect (2000) 2.52
Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol (1991) 2.30
"Sniffin' sticks": screening of olfactory performance. Rhinology (1996) 2.17
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab. Eye (Lond) (2011) 2.05
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet (2000) 2.02
Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol (2008) 1.97
Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye (Lond) (2008) 1.96
Molecular characterization and biological function of the movement protein of tobacco mosaic virus in transgenic plants. Proc Natl Acad Sci U S A (1990) 1.89
Nonunion of the mandible: an analysis of contributing factors. J Oral Maxillofac Surg (2000) 1.83
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene (1998) 1.81
Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke (2000) 1.79
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery (2000) 1.75
Neuropathic shoulder arthropathy (Charcot joint) associated with syringomyelia. Neurology (1998) 1.73
Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients. Crit Care Med (2001) 1.70
Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68
Emergency physician workload: a time study. Ann Emerg Med (1993) 1.66
A universal spine tester for in vitro experiments with muscle force simulation. Eur Spine J (1994) 1.65
Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (2000) 1.64
[Bilateral acute syphilitic posterior placoid chorioretinopathy--angiographic and autofluorescence characteristics]. Ophthalmologe (1999) 1.59
The Roseto effect: a 50-year comparison of mortality rates. Am J Public Health (1992) 1.58
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]. Klin Monbl Augenheilkd (2013) 1.58
Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy (2009) 1.56
Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55
A case control study of multiple myeloma at four nuclear facilities. Ann Epidemiol (2000) 1.55
The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5. Blood (1988) 1.54
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J (2004) 1.48
Re: Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies by I. S. F. Chan, Statistics in Medicine, 17, 1403-1413 (1998) Stat Med (1999) 1.45
Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation. Br J Ophthalmol (1999) 1.44
[Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study]. Ophthalmologe (2002) 1.43
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41
Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40
[The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI]. Zentralbl Chir (2010) 1.40
The separate determination of human pepsin and gastricsin. Proc Soc Exp Biol Med (1966) 1.40
Circadian rhythm disorders in manic-depressives. Biol Psychiatry (1978) 1.40
[Trends in inpatient treatment in ophthalmology in Germany]. Ophthalmologe (2013) 1.38
[Immunonutritive enteral feeding in the critically ill]. Anaesthesist (2002) 1.38
Mobility impairments and use of preventive services in women with multiple sclerosis: observational study. BMJ (2001) 1.38
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye (Lond) (2009) 1.38
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol (2008) 1.38
Altered function of the tobacco mosaic virus movement protein in a hypersensitive host. Virology (1991) 1.37
Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol (1994) 1.33
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res (2004) 1.33
Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Chem Biol (1999) 1.32
Prevalence of evidence of prior myocardial infarction, hypertension, diabetes and obesity in three neighboring communities in Pennsylvania. Am J Med Sci (1967) 1.31
Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology (1993) 1.29
Plasmodesmata: the intercellular organelles of green plants. Trends Cell Biol (1993) 1.28
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Meta-analysis of blood pressure tracking from childhood to adulthood and implications for the design of intervention trials. Acta Paediatr (2010) 1.28
Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomised-controlled clinical trial. Int J Stroke (2009) 1.27
Vestibular paroxysmia: diagnostic features and medical treatment. Neurology (2008) 1.27
Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) (2002) 1.26
Detection of enteric viruses and bacterial indicators in German environmental waters. Arch Virol (2005) 1.25
Social aspects of coronary heart disease in two adjacent, ethnically different communities. Am J Public Health Nations Health (1966) 1.24
The TMV movement protein: role of the C-terminal 73 amino acids in subcellular localization and function. Virology (1991) 1.23
Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21
The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol (1995) 1.21
Imaging of retinal autofluorescence in patients with age-related macular degeneration. Retina (1997) 1.20
[Intravitreal bevacizumab for neovascular age-related macular degeneration]. Ophthalmologe (2006) 1.20
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19
Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol (2001) 1.18
Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol (1996) 1.17
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol (1999) 1.16
Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry. Eye (Lond) (2008) 1.14
Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol (2006) 1.14
Roseto revisited: further data on the incidence of myocardial infarction in Roseto and neighboring Pennsylvania communities. Trans Am Clin Climatol Assoc (1974) 1.14
Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14
Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie (2004) 1.13
The psyche and the stomach. A historical vignette. Gastroenterology (1981) 1.13
A method for selecting criteria to evaluate medical care. Am J Public Health (1978) 1.13
Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol (2008) 1.13
Eubacterial proteasomes. Mol Biol Rep (1997) 1.12
A Comprehensive Assessment Tool for Patient Registry Software Systems: The CIPROS Checklist. Methods Inf Med (2015) 1.12
Modelling the natural history of geographic atrophy in patients with age-related macular degeneration. Ophthalmic Epidemiol (2005) 1.11
Inflammatory response after laparoscopic and conventional colorectal resections - results of a prospective randomized trial. Langenbecks Arch Surg (2000) 1.09
Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol (2008) 1.09